Three important tests for HHV-6 will now be available at Coppe Labs, including two that are not available commercially at any other location: the mRNA test for assessing active infection and immunohistochemistry analysis for biopsy samples.
The inherited strain of HHV-6A in an immunosuppressed infant activated and caused hemophagocytic syndrome that was responsive to antiviral treatment. The isolated strain matched that of his ciHHV6 father.
Two papers published this month highlight the potential of the new 3rd generation PCR assays in the field of HHV-6 diagnostics.
HIV+ individuals with ciHHV-6 may experience lower severity HIV disease.
Additional evidence that shortened telomeres can cause the release and possible activation of integrated HHV-6.
Dr. Bhupesh Prusty and Professor Thomas Rudel from Biozentrum University have published several articles on the phenomenon of ciHHV-6 activation including a study on the interaction between Chlamydia infection and ciHHV-6. We interviewed them about the implications of these findings, their current studies, and what lies ahead for this team in the field of ciHHV-6 research.
The frequency of ciHHV-6 in the Province of Quebec (Canada) appears to be lower than that observed in US and UK.
Researchers at the University Of South Florida’s Morsani College Of Medicine have published findings that suggest ciHHV-6 is the possible cause of some CFS cases
A laboratory at the University of Wurzburg has published evidence that Chlamydia trachomatis may induce the activation of ciHHV-6.
A newly developed assay is now commercially available for clinical diagnosis of chromosomally integrated HHV-6 (ciHHV-6)
New findings suggest that ciHHV-6 can be reactivated and then acquired transplacentally.
An international group of HHV-6 experts, investigators and clinicians have published a comprehensive review of chromosomally integrated HHV-6 (ciHHV-6). The article, entitled “Chromosomally Integrated human herpesvirus-6: questions and answers,” is written in response to the widespread confusion in the medical community on how to test or diagnose the condition, as well as how to treat a patient with ciHHV-6 who may or may not have symptoms consistent with HHV-6 reactivation.
The reactivation of HHV-6 in transplant recipients has long been known to induce clinical complications and poor outcomes following transplantation. However, the clinical relevance of transplant patients with ciHHV-6…
- Page 2 of 2